Steris (STE -1.19%), a healthcare company specializing in infection prevention and sterilization products and services, reported Q1 FY2026 earnings on August 6, 2025. The most notable news from the release was that while the company delivered solid year-over-year growth and margin gains, both revenue (GAAP) and non-GAAP earnings per share (EPS) fell short of analyst expectations. Actual revenue (GAAP) reached $1,391.1 million, compared to an analyst estimate of $1,447.8 million, while adjusted EPS came in a ...